Free Trial
OTCMKTS:EMIS

Emisphere Technologies (EMIS) Stock Price, News & Analysis

Emisphere Technologies logo
$7.81 0.00 (0.00%)
As of 12/9/2020

About Emisphere Technologies Stock (OTCMKTS:EMIS)

Key Stats

Today's Range
$7.81
$7.81
50-Day Range
$7.81
$7.81
52-Week Range
$4.06
$9.16
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EMIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emisphere Technologies and its competitors with MarketBeat's FREE daily newsletter.

EMIS Stock News Headlines

Exco Technologies Limited (XTC.TO)
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
Insulin pill could free diabetics from jabs
See More Headlines

EMIS Stock Analysis - Frequently Asked Questions

Emisphere Technologies' stock was trading at $7.81 at the beginning of 2025. Since then, EMIS stock has increased by 0.0% and is now trading at $7.81.

Emisphere Technologies Inc. (OTCMKTS:EMIS) posted its quarterly earnings results on Friday, May, 12th. The company reported $0.04 EPS for the quarter. The business had revenue of $0.22 million for the quarter.

Shares of EMIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emisphere Technologies investors own include Novo Nordisk A/S (NVO), Fulcrum Therapeutics (FULC), VIVUS (VVUS), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA) and Capricor Therapeutics (CAPR).

Company Calendar

Last Earnings
5/12/2017
Today
8/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:EMIS
CIK
805326
Employees
6
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:EMIS) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners